Gannet BioChem, a specialty chemical Contract Development and Manufacturing Organization (CDMO), has promoted Bob Rodebaugh to Vice President of Technology. This move comes after Gannet BioChem named a new CEO, CFO and COO earlier this year. In this role, Rodebaugh will oversee process and analytical development as well as program management, ensuring customers benefit from a seamless and integrated path throughout the drug development lifecycle. He brings CDMO experience and most recently...